Norovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Phase I Norovirus Challenge Model
Condition:   Gastroenteritis Norovirus Intervention:   Biological: Norovirus GII.4 Challenge Pool Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2019 Category: Research Source Type: clinical trials

Safety Study to Determine the Optimal Human Challenge Dose for Norovirus GII.4 CIN-3 Batch No.: 01-16C3
Condition:   Gastroenteritis Norovirus Intervention:   Biological: Norovirus GII.4 Challenge Pool Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2019 Category: Research Source Type: clinical trials

Ph 1b Safety/Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines With Monovalent or Bivalent Dosing
Condition:   Norovirus Infection Interventions:   Biological: VXA-G1.1-NN;   Biological: VXA-G2.4-NS;   Biological: Placebo Tablets Sponsor:   Vaxart Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2019 Category: Research Source Type: clinical trials

Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines
Condition:   Norovirus Infection Interventions:   Biological: VXA-G1.1-NN;   Biological: VXA-G2.4-NS;   Biological: Placebo Tablets Sponsor:   Vaxart Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2019 Category: Research Source Type: clinical trials